Body Contouring Devices Market (2026 - 2033)

Body Contouring Devices Market Summary

The global body contouring devices market size was valued at USD 1.9 billion in 2025 and is projected to grow from USD 2.2 billion in 2026 to USD 5.7 billion in 2033, at a CAGR of 14.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% of revenue in 2025. Body contouring devices can be invasive, non-invasive, or minimally invasive and aim to reshape an area of the body. This can be done surgically via liposuction or through less invasive methods like cryolipolysis, injection lipolysis, radiofrequency lipolysis, and laser lipolysis. The main goal of body contouring procedures is to eliminate unwanted fat and achieve firmness in the treatment area.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The market is experiencing steady growth, driven by the rising prevalence of obesity linked to sedentary lifestyles and unhealthy dietary habits, as well as growing consumer awareness of aesthetic procedures. Continuous advancements in body contouring technologies have improved the safety, efficacy, and clinical outcomes of both surgical and non-surgical procedures, encouraging wider adoption. In addition, strategic initiatives by leading market participants, including mergers and acquisitions, new product launches, and partnerships to expand product portfolios and strengthen distribution networks, are expected to further support market growth over the forecast period.

Non-invasive fat reduction, or nonsurgical fat reduction, refers to minimally invasive treatments that break down stubborn subcutaneous fat pockets beneath the skin. Major factors driving market growth include rising demand for body-contouring treatments, as they are non-invasive and require no downtime after the procedure. SculpSure, developed by Cynosure LLC, is a non-invasive body-contouring laser device that targets and destroys around 24% of unwanted fat cells in 25 minutes.

A sedentary lifestyle is a major underlying cause of obesity, disease, and disability. Levels of physical inactivity are very high in all developed and developing countries. According to the World Obesity Federation, it is projected that over half the global population, around 4 billion people, will be living with overweight and obesity by 2035. Increased urbanization has contributed immensely to the increase in sedentary lifestyles, which in turn has escalated the prevalence of obesity globally.

Analyst Perspective

The market is experiencing robust growth, driven by the rising prevalence of obesity, increasing demand for aesthetic procedures, and ongoing technological advancements in body-contouring solutions. Non-invasive and minimally invasive devices account for the largest market share owing to their favorable safety profile, shorter recovery periods, and cost-effectiveness compared to traditional surgical procedures. North America remains the leading regional market, supported by well-established healthcare infrastructure, high consumer awareness, and widespread adoption of advanced aesthetic technologies. Meanwhile, the Asia Pacific is expected to register the fastest growth, driven by rising disposable incomes, expanding healthcare investments, increasing medical tourism, and the growing presence of global market players. Companies are strengthening their market position through continuous product innovation, regulatory approvals, strategic collaborations, and geographic expansion to meet the evolving demand for advanced body-contouring solutions.

Type Insights

The noninvasive and minimally invasive devices segment dominated the market share, at approximately 78.0%, in 2025. Entry of various products, investment by market players, and high demand for non-invasive and minimally invasive procedures due to their safe and cost-effective nature are driving the market. The market expansion is fueled by the growing popularity of noninvasive body-contouring treatments that require no recovery time.

The invasive devices segment is expected to register strong growth over the forecast period. Invasive body contouring procedures, such as Liposuction or lipolysis, have remained among the most popular and in-demand plastic surgery procedures for body contouring and are particularly effective in removing fat from the legs, abdomen, back, arms, face, and neck. Ongoing advancements in minimally invasive surgical technologies support the segment's growth. For instance, in May 2025, Apyx Medical received U.S. FDA clearance for its AYON Body Contouring System, an all-in-one platform designed for fat removal, tissue contraction, and electrosurgical applications during body contouring procedures.

Regional Insights

The North America body contouring devices market dominated with a revenue share of 35.0% in 2025. This is attributed to the growing geriatric population, a strong medical infrastructure, well-established reimbursement policies, the presence of key market players, and advancements in aesthetic body-contouring procedures. The regional market is also benefiting from continued innovation in non-invasive aesthetic technologies. For instance, in November 2025, Venus Concept received U.S. FDA clearance for the Venus NOVA platform, a next-generation multi-application system, for non-invasive body contouring, muscle conditioning, cellulite reduction, and skin treatments, thereby strengthening the company's body-contouring portfolio in the U.S. market. Moreover, attributes such as high acceptance of and openness to body-contouring treatments, and a growing appearance-conscious customer pool are likely to propel the non-invasive body-contouring market in North America.

To learn more about this report, Download Free Sample Report

U.S. Body Contouring Devices Market Trends

The body contouring devices market in the U.S. dominated North America in 2025. As consumers in the country become more aware of their appearance and seek ways to enhance their physical attributes, a significant shift has occurred from traditional surgical methods to non-invasive alternatives. With rising obesity rates across the continent, there is a growing need for effective solutions to manage and address excess body fat. Body contouring devices offer an attractive option for individuals seeking to complement their weight-loss efforts or achieve specific body-shape goals.

Asia Pacific Body Contouring Devices Market Trends

The body contouring devices market in the Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Major Asia-Pacific markets, including China, India, Japan, and South Korea, continue to invest in healthcare infrastructure, aesthetic technologies, and research and development, thereby supporting regional market growth. The market is also witnessing strategic expansion by global aesthetic device manufacturers. For instance, in April 2025, SofWave Medical received regulatory clearance from Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its SUPERB technology, enabling the company to expand its commercial footprint across the Asia Pacific region, including Japan, Australia, Taiwan, and South Korea. Asian countries have long been a renowned hub for aesthetic procedures. Numerous fat-reduction procedures are performed in countries such as China, South Korea, and Japan each year. Cost-effective and high-quality treatment, rising disposable income, and growing obese & geriatric population are driving the market in the APAC region.

China body contouring devices market held a significant share in 2025. The proliferation of clinics and wellness centers across the country offering body-contouring treatments increases consumer access to these services. As more establishments incorporate advanced body contouring technologies into their offerings, the market becomes more competitive and accessible. Additionally, the rise of specialized aesthetic clinics and the growing focus on holistic wellness contribute to the increasing availability and popularity of body contouring devices.

Key Body Contouring Devices Company Insights

The body contouring devices industry features a range of global, regional, and local players, making it highly competitive. The world’s leading companies are using partnerships, collaborations, acquisitions, mergers, and agreements as strategies to withstand the intense competition and increase their market share.

Key Body Contouring Devices Companies

The following key companies have been profiled for this study on the body contouring devices market:

• Cynosure LLC

• Alma Lasers

• AbbVie Inc.

• Merz Pharma GmbH & Co. KGaA

• Candela Corporation

• Solta Medical Inc.

• Bausch Health Companies, Inc.

• Lutronic Corporation

• InMode Ltd

• Fotona d.o.o.

• Sofwave Medical LTD

• Sciton Inc

• Lumenis

Recent Developments

• In March 2025, Candela announced the global launch of the Glacē treatment at the American Academy of Dermatology (AAD) Annual Meeting, expanding its medical aesthetics portfolio with an advanced hydrodermabrasion solution integrating dual-mode cupping massage and LED technology.

• In April 2024, Cartessa Aesthetics launched PHYSIQ 360, a groundbreaking non-invasive body-contouring treatment designed to enhance patients' aesthetic outcomes. This innovative technology combines muscle stimulation and fat-reduction techniques to deliver comprehensive body-sculpting results.

• In January 2024, Cynosure LLC merged with Lutronic Aesthetic Lasers to enhance its capabilities in delivering cutting-edge solutions for various aesthetic procedures. The merger is expected to improve its ability to provide advanced treatments for skin rejuvenation, body contouring, and other aesthetic procedures.

Global Body Contouring Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global body contouring devices market report based on type and region:

• Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Non-invasive and Minimally Invasive Devices

    • Nonsurgical Skin Resurfacing

    • Nonsurgical Skin Tightening

    • Cellulite treatment

    • Others

  • Invasive Devices

    • Liposuction

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • UAE

    • South Africa